Supriya Lifescience and Odisha’s Kalinga Institute of Industrial Technology (KIIT) have collaborated to develop an oral cancer detection kit.
The initiative marks a portfolio-diversification by the Mumbai-based active pharmaceutical ingredients (API) maker.
The ‘Quickblue oral kit’ is designed to detect oral cancer in a cost-effective and efficient manner, the company said, adding that it had filed for a patent on the kit.
Satish Wagh, Supriya Lifescience Chairman said, the oral kit could “reduce the cost of oral cancer detection significantly, eliminating the need for multiple biopsies in cases of non-healing oral ulcers.” The product was relevant in the country and the Asian sub-continent, he added, “where a significant percentage of oral cancer patients are found.”
“This initiative represents a step towards diversifying the product portfolio of Supriya Lifescience,” said Wagh, adding that they aimed to expand and grow over the next decade. Mrutyunjay Suar, Director-General (Research and Development and Innovation) at KIIT University, said their research portfolio was in segments including biotechnology, medicine; rural management and social and mental health.